Application Note

Efficient-Pro Medium And Feeds Deliver Strong Product Quality While Enhancing Productivity In CHO-K1 And CHO-S Cells

Cell culture pipette GettyImages-1173385629

Once a therapeutic antibody is identified and successfully produced at development scales, manufacturers often consider enhancing productivity as the next challenge for scale-up. Although the importance of strong productivity is undeniable, a more crucial challenge can be delivering sustained or improved product quality with productivity enhancements. Having consistent product quality is essential to ensure patient safety and product efficacy. Impurities can affect downstream purification by requiring additional processes and reducing product yields. Therefore, manufacturers are placing greater emphasis on optimizing upstream processes with the goals of minimizing impurities, improving product quality, and decreasing time to market. The early identification of a robust, commercially available, optimized platform medium and cell line–specific feed could be the keys to achieving strong productivity with sustained or improved product quality and delivering product to market more rapidly.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Thermo Fisher Scientific Bioproduction